Sale!

CYP1B1 Gene Glaucoma primary type 3A Genetic Test

4,400 د.إ

-21%

The CYP1B1 Gene Glaucoma Primary Type 3A Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the CYP1B1 gene that are associated with Primary Congenital Glaucoma (PCG), specifically type 3A. This form of glaucoma is a severe eye condition that typically presents itself in infancy or early childhood, leading to increased intraocular pressure, optic nerve damage, and potentially, loss of vision if left untreated. The CYP1B1 gene plays a critical role in the development of the eye’s drainage system; mutations in this gene can disrupt this system, leading to the accumulation of eye fluid and increased pressure.

The test is priced at 4400 AED and involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of genetic alterations in the CYP1B1 gene. Identifying these mutations can provide valuable information for the early diagnosis and management of glaucoma, allowing for timely intervention and a better prognosis for affected individuals. Additionally, this test can be useful for families with a history of Primary Congenital Glaucoma, offering them an opportunity for genetic counseling and informed decision-making regarding family planning. DNA Labs UAE utilizes advanced genetic testing technologies to ensure accurate and reliable results, contributing to the effective detection and management of glaucoma in susceptible individuals.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CYP1B1 Gene Glaucoma primary type 3A Genetic Test

Cost: AED 4400.0

Components:

  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ophthalmology Disorders
  • Doctor: Ophthalmologist
  • Test Department: Genetics

Pre Test Information:

Clinical History of Patient who is going for CYP1B1 Gene Glaucoma, primary type 3A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CYP1B1 Gene Glaucoma, primary type 3A NGS Genetic DNA Test gene CYP1B1.

Test Details:

The CYP1B1 gene is associated with primary type 3A glaucoma, a rare form of glaucoma that typically affects infants and young children. This condition is characterized by high intraocular pressure, optic nerve damage, and visual impairment.

NGS genetic testing for the CYP1B1 gene can identify mutations or variations in the gene that are associated with an increased risk of developing primary type 3A glaucoma. This information can be used to diagnose the condition early, allowing for prompt treatment and management to prevent vision loss.

NGS testing involves sequencing the entire CYP1B1 gene, which can identify both known and unknown variants. This comprehensive approach can provide more accurate and reliable results compared to traditional genetic testing methods.

It is important to note that while genetic testing can provide valuable information about an individual’s risk of developing primary type 3A glaucoma, it is not a guarantee that the condition will develop. Other factors, such as environmental and lifestyle factors, can also play a role in the development of glaucoma. Therefore, genetic testing should be used in conjunction with regular eye exams and other preventative measures to ensure optimal eye health.

Test Name CYP1B1 Gene Glaucoma primary type 3A Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ophthalmology Disorders
Doctor Ophthalmologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CYP1B1 Gene Glaucoma, primary type 3A NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CYP1B1 Gene Glaucoma, primary type 3A NGS Genetic DNA Test gene CYP1B1
Test Details

The CYP1B1 gene is associated with primary type 3A glaucoma, a rare form of glaucoma that typically affects infants and young children. This condition is characterized by high intraocular pressure, optic nerve damage, and visual impairment.

NGS genetic testing for the CYP1B1 gene can identify mutations or variations in the gene that are associated with an increased risk of developing primary type 3A glaucoma. This information can be used to diagnose the condition early, allowing for prompt treatment and management to prevent vision loss.

NGS testing involves sequencing the entire CYP1B1 gene, which can identify both known and unknown variants. This comprehensive approach can provide more accurate and reliable results compared to traditional genetic testing methods.

It is important to note that while genetic testing can provide valuable information about an individual’s risk of developing primary type 3A glaucoma, it is not a guarantee that the condition will develop. Other factors, such as environmental and lifestyle factors, can also play a role in the development of glaucoma. Therefore, genetic testing should be used in conjunction with regular eye exams and other preventative measures to ensure optimal eye health.